Sysmex Astrego is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. The company was founded as Astrego Diagnostics in March 2017 and was acquired by Sysmex Corporation, Japan in May 2022 when the new entity Sysmex Astrego AB was formed. The company name comes from Antibiotic Susceptibility Testing – AST, and rego – being latin for guide, steer or manage. Our mission is to help in the global fight against antimicrobial resistance (AMR) and our products are designed to guide physicians in the selection of effective antibiotic treatments to improve patient outcomes and make antibiotic stewardship easy. Our team combines multidisciplinary scientific excellence with seasoned entrepreneurs and diagnostic industry management.